Literature DB >> 1937785

An interleukin-1 inhibitor in gingival crevicular fluid of patients with chronic inflammatory periodontal disease.

H Kabashima1, K Maeda, H Iribe, K Yamashita, T Hirofuji, Y Iwamoto, M Aono.   

Abstract

The gingival crevicular fluid of a patient(s) with marginal periodontal disease contained an activity inhibitory to interleukin-1 (IL-1). The inhibitory activity could be detected after the depletion of IL-1 alpha by the use of a specific antibody (anti-human recombinant IL-1 alpha monoclonal antibody)-conjugated Sepharose column. The inhibitory activity was not due to a toxic effect on the thymocytes since IL-1 alpha-depleted gingival crevicular fluid did not affect the incorporation of [3H]thymidine in either the presence or absence of concanavalin A. The inhibitory activity was exerted against both IL-1 alpha and IL-1 beta. The inhibitory factor did not have any effect on IL-2-induced proliferation of concanavalin A-activated spleen cells. The inhibitor was heat labile. Gel filtration on a Superose 12 column revealed the IL-1 inhibitor to have two major peaks, one in the molecular size range of 12 to 14 kDa and the other below a molecular size of 10 kDa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937785      PMCID: PMC259029          DOI: 10.1128/iai.59.11.4271-4274.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Native interleukin 1 inhibitors.

Authors:  J W Larrick
Journal:  Immunol Today       Date:  1989-02

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Partial characterization of an interleukin-1-like factor in human gingival crevicular fluid from patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; Y Iwamoto; T Hirofuji; M Yoneda; K Yamashita; M Aono
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors.

Authors:  J Andersson; K O Grönvik; E L Larsson; A Coutinho
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

5.  Isolation of an interleukin-1-like factor from human joint effusions.

Authors:  D D Wood; E J Ihrie; C A Dinarello; P L Cohen
Journal:  Arthritis Rheum       Date:  1983-08

6.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Interleukin 1 activity in normal human urine.

Authors:  E S Kimball; S F Pickeral; J J Oppenheim; J L Rossio
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells.

Authors:  L J Walsh; P E Lander; G J Seymour; R N Powell
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

9.  An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.

Authors:  W P Arend; F G Joslin; R C Thompson; C H Hannum
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

10.  Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.

Authors:  G Scala; Y D Kuang; R E Hall; A V Muchmore; J J Oppenheim
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.